Evidence map›Paper›PMID 30421784›Full record

ReviewJornal brasileiro de nefrologia

Hypertension in patients on dialysis: diagnosis, mechanisms, and management.

Sérgio Gardano Elias Bucharles, Krissia K S Wallbach, Thyago Proença de Moraes, Roberto Pecoits-Filho

Abstract readReview
In one paragraph

Review in Jornal brasileiro de nefrologia. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Association of serum potassium with decline in residual kidney function in incident hemodialysis patients.Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association · 2022
    Article
  20. Tight Blood Pressure Control in Chronic Kidney Disease.Journal of cardiovascular development and disease · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sérgio Gardano Elias BucharlesUniversidade Federal do Paraná, Hospital de Clínicas, Curitiba, PR, Brasil.ORCID http://orcid.org/0000-0002-9051-5045
Krissia K S WallbachUniversidade Federal do Paraná, Hospital de Clínicas, Curitiba, PR, Brasil.
Thyago Proença de MoraesPontifícia Universidade Católica do Paraná, Faculdade de Medicina, Curitiba, PR, Brasil.
Roberto Pecoits-FilhoPontifícia Universidade Católica do Paraná, Faculdade de Medicina, Curitiba, PR, Brasil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hypertension (blood pressure > 140/90 mm Hg) is very common in patients undergoing regular dialysis, with a prevalence of 70-80%, and only the minority has adequate blood pressure (BP) control. In contrast to the unclear association of predialytic BP recordings with cardiovascular mortality, prospective studies showed that interdialytic BP, recorded as home BP or by ambulatory blood pressure monitoring in hemodialysis patients, associates more closely with mortality and cardiovascular events. Although BP is measured frequently in the dialysis treatment environment, aspects related to the measurement technique traditionally employed may be unsatisfactory. Several other tools are now available and being used in clinical trials and in clinical practice to evaluate and treat elevated BP in chronic kidney disease (CKD) patients. While we wait for the ongoing review of the CKD Blood Pressure KIDGO guidelines, there is no guideline for the dialysis population addressing this important issue. Thus, the objective of this review is to provide a critical analysis of the information available on the epidemiology, pathogenic mechanisms, and the main pillars involved in the management of blood pressure in stage 5-D CKD, based on current knowledge.

Indexed as

Peritoneal DialysisAntihypertensive AgentsBlood Pressure Monitoring, AmbulatoryDiet, Sodium-RestrictedHumansHypertensionPrevalenceRenal Insufficiency, ChronicRisk FactorsAntihypertensive Agents

Identifiers

PMID30421784
PMCPMC6788847

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.